tiprankstipranks
Trending News
More News >

Thiogenesis Boosts Investor Relations with New Partnership

Story Highlights
Thiogenesis Boosts Investor Relations with New Partnership

Thiogenesis Therapeutics Corp (TSE:TTI) has released an update.

Confident Investing Starts Here:

Thiogenesis Therapeutics Corp., a clinical-stage biopharmaceutical company, has engaged Capital Analytica for investor relations services to enhance social media presence and investor engagement. The company agreed to pay quarterly fees and grant stock options under the new agreement. Additionally, Thiogenesis has issued restricted share units to an officer, with both stock options and RSUs subject to regulatory approval.

For further insights into TSE:TTI stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App